Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis

R. P. McQuellon, B. W. Loggie, R. A. Fleming, G. B. Russell, A. B. Lehman, T. D. Rambo

Research output: Contribution to journalArticlepeer-review

140 Scopus citations

Abstract

Aims: This study assessed the functional status and quality of life (QOL) of patients with disseminated peritoneal cancer (DPC) before and after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy (IPHC). Methods: Patients with confirmed or suspected diagnosis of gastro-intestinal cancer including stomach, pancreas, hepatobiliary and colorectal cancer with peritoneal implants were enrolled in the study. Sixty-four patients completed the Functional Assessment of Cancer Therapy-Colon (FACT-C) scale and several other instruments at baseline. Forty-eight, 40, 39 and 31 patients were assessed at approximately 2 weeks post-surgery, and 3, 6 and 12 months respectively. Results. There was a significant overall effect on the physical (P=0.0025), emotional (P

Original languageEnglish (US)
Pages (from-to)65-73
Number of pages9
JournalEuropean Journal of Surgical Oncology
Volume27
Issue number1
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis'. Together they form a unique fingerprint.

Cite this